A complete application in a minute
Tailored resume and cover letter, ready to send.
Medpace Clinical Research India Pvt. Ltd. invites fresh graduates to join as Clinical Research Associate (CRA) – Entry at Navi Mumbai. No prior monitoring experience required; successful candidates will undergo Medpace’s PACE® CRA Training Program before taking on independent monitoring activities.
This role offers international exposure in clinical research, comprehensive training, and a clear career path within a globally respected CRO, with travel across India to study sites and sponsors.
Clinical Research Associates (CRAs) are among the most sought-after professionals in the pharmaceutical and clinical research industry. They play a crucial role in ensuring that clinical trials are conducted according to international regulatory standards while protecting participant safety and maintaining the integrity of clinical data. As the clinical research industry continues to expand across India, the demand for skilled CRAs is increasing rapidly, making it an excellent career choice for pharmacy and life sciences graduates.
Medpace Clinical Research India has announced an exciting opportunity for fresh graduates by opening applications for the position of Clinical Research Associate (CRA) – Entry at its Navi Mumbai office. One of the biggest advantages of this opportunity is that prior monitoring experience is not mandatory. Selected candidates receive comprehensive training through Medpace’s globally recognized PACE® (Professionals Achieving CRA Excellence) Training Program before taking responsibility for independent monitoring activities.
If you are passionate about clinical research, patient safety, and drug development while looking for a career with international exposure, this opportunity could be the ideal starting point.
Particulars
Details
Company Medpace Clinical Research India Pvt. Ltd.
Position Clinical Research Associate (CRA) – Entry
Location Navi Mumbai (Ghansoli)
Employment Type Full-Time
Experience 0–2 Years (Freshers Eligible)
Qualification B.Pharm, M.Pharm, Pharm.D, Nursing, Biotechnology & Life Sciences
Training PACE® CRA Training Program
Travel Requirement 60–80% National Travel
Medpace is a globally recognized Contract Research Organization (CRO) providing clinical development services to pharmaceutical, biotechnology, and medical device companies. The organization manages studies across multiple therapeutic areas and supports sponsors from early clinical development through regulatory approval.
The company is known for investing heavily in employee development and is widely respected for its structured CRA training program, making it one of the preferred employers for candidates starting careers in clinical research.
A Clinical Research Associate acts as the bridge between the sponsor, Contract Research Organization, and clinical trial sites. Their primary responsibility is to monitor clinical studies and ensure that every trial follows Good Clinical Practice (GCP), study protocols, and regulatory requirements.
CRAs regularly visit hospitals and research sites to review patient records, verify study documentation, assess investigational product accountability, and ensure accurate reporting of clinical data. Their work directly contributes to patient safety and the successful completion of clinical trials.
One of the biggest advantages of joining Medpace is its internationally recognized PACE® CRA Training Program. Instead of expecting fresh graduates to possess monitoring experience, the company provides structured classroom learning and practical exposure before assigning independent monitoring responsibilities.
Fresh graduates are encouraged to apply. Previous experience as a Clinical Research Coordinator or Research Assistant can be an added advantage.
A Clinical Research Associate role provides excellent long-term career opportunities. With experience, professionals can advance to Senior CRA, Lead CRA, Clinical Trial Manager, Project Manager, Clinical Operations Manager, and eventually leadership positions within global pharmaceutical companies and CROs.